TEMOBEL

Temozolomide

Composition: each capsule contains:

active ingredients: temozolomide – 20 mg, 100 mg or 250 mg.

Therapeutic indications

Adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy.

Children over the age of 3 years and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.

	АТС code
	L01AX03
	Pharmaceutical form
	capsules 20 mg, 100 mg, 250 mg
	Storage conditions
	Store in protected from moisture and light place at temperature below 25°C.